ENHO and type 2 diabetes mellitus: Adropin plays a significant role in T2DM and associated cardiovascular disorders by influencing endothelial function and atherosclerosis, independently associated with angiographic severity of coronary atherosclerosis, suggesting that serum adropin serves as a novel predictor of coronary atherosclerosis [95].